"and ymav4294, that is correct. Prima are enrolling patients from the point of diagnosis to monitor their treatment through surgery and chemo before Cvac treatment begins."-DCHECKERS
Yes that is my understanding also. However they are taking the dendritic cells(immune) from the patient BEFORE chemo when the immune response will be stonger - and administering the CVAC (treated dendritic cells) AFTER chemo--Martin Rogers made a point of mentioning this to me and it is mentioned elsewhere in public documents.
cheers
Birdseye
sydney shareholder presentation, page-6
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.005(1.27%) |
Mkt cap ! $569.8M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 39.0¢ | $1.746M | 4.422M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7395 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 94636 | 3 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |